Weng Wen-Jun, Pan Li, Fang Jian-Pei, Xu Lv-Hong
Department of Pediatrics, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120,Guangdong Province, China. E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1266-70. doi: 10.7534/j.issn.1009-2137.2013.05.036.
This study was purposed to compare the effect of 3 different cell components for expanding CD4(+) CD25(+) Treg in vitro, and identify their immunosuppressive function. CD4(+) T cells, CD4(+) CD25(-)T cells and CD4(+) CD25(+)T cells were isolated from mouse splenocytes by MACS and then expanded in vitro. Phenotype of the T cell lines and expression of the FOXP3 was determined by flow cytometry. The inhibitory effect of expanded CD4(+) CD25(+) T cells on CD4(+) CD25(-)T cells was tested by MLR method. The results showed that the Treg cells from all the three groups were expanded significantly after culture for 2 weeks. In the CD4(+) T cells group, the proliferation rate was (77.8 ± 5.32) folds with a percentage of Treg cells increasing from (6.61 ± 1.00)% to (15.33 ± 1.31)%. The proliferation rate in the CD4(+) CD25(-) T cells group was (95.20 ± 7.67) folds, with the percentage of CD4(+) CD25(+) T cells raising from (0.37 ± 0.13)% to (9.84 ± 0.98)%. The proliferation rate in the CD4(+) CD25(+) T cells group was (41.20 ± 6.92) folds, the proportion of Treg cells decreased from (86.75 ± 1.25)% to (85.32 ± 1.62)%, and the expression of Foxp3 decreased from (76.92 ± 1.72)% to (75.33 ± 2.11)% during the culture, there were not significant differences in the cell purity and the expression of Foxp3, compared with pre-amplification. The inhibitory test showed that the expanded CD4(+) CD25(+) T cells could inhibit the proliferation of CD4(+) CD25(-) T cells in vitro in a cell dose-dependent manner. It is concluded that the amplification of CD4(+) CD25(+) Treg cells is successful in vitro, especially in the CD4(+) CD25(+) T cells group, the cell purity and Foxp3 gene is not obviously changes after amplification.
本研究旨在比较3种不同细胞成分在体外扩增CD4(+) CD25(+)调节性T细胞(Treg)的效果,并鉴定其免疫抑制功能。通过磁珠分选法(MACS)从小鼠脾细胞中分离出CD4(+) T细胞、CD4(+) CD25(-)T细胞和CD4(+) CD25(+)T细胞,然后进行体外扩增。采用流式细胞术检测T细胞系的表型及叉头框蛋白P3(FOXP3)的表达。通过混合淋巴细胞反应(MLR)法检测扩增后的CD4(+) CD25(+) T细胞对CD4(+) CD25(-)T细胞的抑制作用。结果显示,培养2周后,三组的Treg细胞均显著扩增。在CD4(+) T细胞组中,增殖率为(77.8 ± 5.32)倍,Treg细胞百分比从(6.61 ± 1.00)%增至(15.33 ± 1.31)%。CD4(+) CD25(-) T细胞组的增殖率为(95.20 ± 7.67)倍,CD4(+) CD25(+) T细胞百分比从(0.37 ± 0.13)%升至(9.84 ± 0.98)%。CD4(+) CD25(+) T细胞组的增殖率为(41.20 ± 6.92)倍,培养过程中Treg细胞比例从(86.75 ± 1.25)%降至(85.32 ± 1.62)%,Foxp3表达从(76.92 ± 1.72)%降至(75.33 ± 2.11)%,与扩增前相比,细胞纯度和Foxp3表达无显著差异。抑制试验表明,扩增后的CD4(+) CD25(+) T细胞可在体外以细胞剂量依赖的方式抑制CD4(+) CD25(-) T细胞的增殖。结论是,CD4(+) CD25(+) Treg细胞在体外扩增成功,尤其是在CD4(+) CD25(+) T细胞组中,扩增后细胞纯度和Foxp3基因无明显变化。